The US Food and Drug Administration's proposed major reorganization for departmental review includes a change stripping complaint-handling responsibilities from the agency’s field organization, the Office of Regulatory Affairs.
Sparked by a lost whistleblower complaint about infant formula manufacturing, the revamping of the FDA's Human Foods Program and field...





